1. Intra-arterial administration of epirubicin in the treatment of Nonresectable hepatocellular carcinoma

   • Epirubicin Study Group for Hepatocellular Carcinoma

   Original Articles Pages: 183 - 189

2. Phase I study of beta-alanyl-melphalan as a potent anticancer drug

   • Bao-Ling Tsay
   • Lloyd Wolfinbarger Jr.

   Original Articles Pages: 190 - 196

3. In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin

   • Hidenobu Takahashi
   • Yasutsuna Sasaki
   • Weon-Seon Hong

   Original Articles Pages: 197 - 200

4. Comparative metabolism and elimination of adriamycin and 4′-epiadriamycin in the rat

   • Trevor W. Sweatman
   • Mervyn Israel

   Original Articles Pages: 201 - 206

5. Relative cardiotoxicity and cytotoxicity of anthraquinonyl glucosaminosides

   • Jon W. Banning
   • Hanley N. Abramson
   • Thomas H. Corbett

   Original Articles Pages: 207 - 212

6. Effects of chronic administration of doxorubicin on plasma levels of prostaglandins, thromboxane B₂, and fatty acids in rats

   • Timothy W. Robison
   • Shri N. Giri

   Original Articles Pages: 213 - 220

7. Activity and distribution studies of etoposide and mitozolomide in vivo and in vitro against human choriocarcinoma cell lines

   • Charles J. Brindley
   • R. Barbara Pedley
   • Edward S. Newlands

   Original Articles Pages: 221 - 225

8. Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis

   • Kapil Bhalla
   • Steven Grant

   Original Articles Pages: 226 - 232

9. Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay

   • Toshiaki Saito
   • Michael E. Berens
   • Charles E. Welander

   Original Articles Pages: 233 - 239

10. Hepatic extraction, metabolism and biliary excretion of doxorubicin in the isolated prefused rat liver

    • Francois Ballet
    • Patricia Vrignaud
    • Raoul Poupon

    Original Articles Pages: 240 - 245

11. In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy

    • S. N. Wolff
    • W. W. Grosh
    • K. R. Hande

    Original Articles Pages: 246 - 249

12. Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies

    • Bayard L. Powell
    • Hyman B. Muss
    • Charles L. Spurr

    Original Articles Pages: 250 - 252

13. Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy

    • Brian L. Samuels
    • Nicholas J. Vogelzang
    • B. J. Kennedy

    Original Articles Pages: 253 - 256

14. Changes in serum iron levels following very high-dose cisplatin

    • C. F. Pollera
    • F. Ameglio
    • C. Parracino

    Original Articles Pages: 257 - 260

15. Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia

    • Joseph D. Borsi
    • Thomas Revesz
    • Dezso Schuler

    Original Articles Pages: 261 - 264

16. A phase II trial of diaziquone in patients with head and neck cancer

    • Francisco Muñiz
    • Enrique Vélez-García
    • Mark Becker

    Original Articles Pages: 265 - 268

17. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules

    • W. K. Lam
    • S. Y. So
    • Mary Ip

    Original Articles Pages: 269 - 271

18. Meeting announcements

    Announcement Pages: 272 - 272